EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients

Aidan Gebhardt iD, Andrea Kreienbühl, Thomas Greuter, Christoph Schlag, Simon Nennstiel, Catherine Saner, Jean-Benoit Rossel, Tina Mauthe, Christian M Meerwein iD, Alain Schoepfer, Michael B Soyka, Alex Straumann und 2 weitere

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 965-975

DOI: 10.1111/apt.70819 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.06.2026. Verfasst von Aidan Gebhardt und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Rhinosinusitis, Eosinophilic Esophagitis, Sinusitis, Rhinitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Swiss EoE Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Both eosinophilic oesophagitis (EoE) and chronic rhinosinusitis (CRS) are type 2 inflammatory conditions sharing pathogenic mechanisms, therapeutic responses and atopic associations. Data on the prevalence of CRS in EoE patients is missing.

Aims

Our aim was to assess the prevalence of CRS‐type symptoms in EoE patients, the quality of life and shared characteristics of patients with both diseases.

Methods

We assessed the point prevalence of CRS in Swiss Eosinophilic Esophagitis Cohort Study patients using a validated screening questionnaire comprising four symptom‐based diagnostic criteria. CRS was defined based on symptoms only (definition A) and including self‐reported CRS diagnosis by a physician (definition B). Point prevalence was tested against population prevalence using two‐sided binomial tests. Secondary outcomes were compared between patients with and without CRS. Multivariable logistic regression models were built to adjust for confounders.

Results

211 patients (54%) answered our questionnaire. Prevalence of CRS‐type symptoms was 21.8% (definition A) or 25.1% (definition B), compared to 8.71% in the general population ( p < 0.0001). CRS status was associated with increased EoE symptom severity. This association persisted after adjustment in multivariable logistic models, most consistently under definition A. 25% reported that their CRS symptoms were more debilitating than their EoE symptoms.

Conclusion

CRS‐type symptoms are two‐ to three times more prevalent in EoE patients than in the general population and substantially impact quality of life. Our findings indicate that CRS may be under‐diagnosed in EoE and support routine CRS screening in EoE patients and cross‐speciality collaboration, particularly as both conditions benefit from therapeutic strategies targeting type 2 inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinosinusitisEosinophilic EsophagitisSinusitisRhinitisHumansFemaleMalePrevalenceSwitzerlandChronic DiseaseQuality of LifeAdultMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesCohort StudiesAgedSymptom BurdenYoung AdultAdolescent

Stichwörter der Autor:innen

atopic comorbiditychronic rhinosinusitiseosinophilic oesophagitisepidemiologytype 2 inflammation

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
  • Department of Internal Medicine, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland.
  • Department of Gastroenterology and Hepatology, Spital Wetzikon, Wetzikon, Switzerland.
  • Department of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Aidan Gebhardt, Christian M Meerwein

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Swiss EoE Foundation

Zitieren

APA

Gebhardt, A., Kreienbühl, A., Greuter, T., Schlag, C., Nennstiel, S., Saner, C., Rossel, J. B., Mauthe, T., Meerwein, C. M., Schoepfer, A., Soyka, M. B., Straumann, A., Biedermann, L., & Swiss EoE Cohort Study Group (2026). Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients. Alimentary Pharmacology & Therapeutics, 64(7), 965-975. https://doi.org/10.1111/apt.70819

Vancouver

Gebhardt A, Kreienbühl A, Greuter T, Schlag C, Nennstiel S, Saner C, et al. Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients. Alimentary Pharmacology & Therapeutics. 2026;64(7):965-975. doi:10.1111/apt.70819

BibTeX
@article{Gebhardt2026,
  author = {Gebhardt, Aidan and Kreienbühl, Andrea and Greuter, Thomas and Schlag, Christoph and Nennstiel, Simon and Saner, Catherine and Rossel, Jean-Benoit and Mauthe, Tina and Meerwein, Christian M and Schoepfer, Alain and Soyka, Michael B and Straumann, Alex and Biedermann, Luc and Swiss EoE Cohort Study Group, Swiss EoE Cohort Study Group},
  title = {Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {965--975},
  doi = {10.1111/apt.70819}
}
Kostenlos starten →